Global Status of Antimicrobial Resistance in Clinical Enterococcus Faecalis Isolates: Systematic Review and Meta-analysis

Overview

Journal Ann Clin Microbiol Antimicrob

Publisher Biomed Central

Specialties Infectious Diseases
Microbiology

Date 2024 Aug 24

PMID 39182092

Authors

Lingbo Guan

Masoumeh Beig

Lina Wang

Tahereh Navidifar

Samaneh Moradi

Faezeh Motallebi Tabaei

Zahra Teymouri

Mahya Abedi Moghadam

Mansour Sedighi

Affiliations

Soon will be listed here.

Abstract

Background: Due to the increasing emergence of antibiotic resistance in Enterococcus faecalis (E. faecalis), it indicated as potentially opportunistic pathogen causing various healthcare-associated and life-threatening diseases around the world.

Objective: The aim of this meta-analysis was to evaluate the weighted pooled resistance rates in clinical E. faecalis isolates based on over time, areas, antimicrobial susceptibility testing (AST), and infection source.

Methods: We searched the studies in PubMed, Scopus, and Web of Science (November 30, 2022). All statistical analyses were carried out using the statistical package R.

Results: The analysis encompassed a total of 74 studies conducted in 28 countries. According to the meta-regression, the chloramphenicol, fosfomycin, imipenem, linezolid, minocycline, norfloxacin, quinupristin-dalfopristin, and tetracycline resistance rate increased over time. Analysis revealed statistically significant differences in antibiotic resistance rates for ampicillin, chloramphenicol, erythromycin, gentamicin, penicillin, rifampicin, teicoplanin, tetracycline, and vancomycin across various countries.

Conclusions: Globally, the prevalence of drug resistant E. faecalis strains are on the increase over time. Daptomycin and tigecycline can be an effective agent for the treatment of clinical E. faecalis infections. Considering the low prevalence of antibiotic resistance in continents of Europe and Australia, it is suggested to take advantage of their preventive strategies in order to obtain efficient results in other places with high prevalence of resistance.

Citing Articles

Relationship Between CRISPR-Cas Systems and Acquisition of Tetracycline Resistance in Non-Clinical Populations in Bulgaria.

Pandova M, Kizheva Y, Hristova P Antibiotics (Basel). 2025; 14(2).

PMID: 40001389 PMC: 11852239. DOI: 10.3390/antibiotics14020145.

Seasonal Trends and Antibiotic Resistance Profiles of Bacterial Pathogens in Indian Clinical Isolates.

B N, Singh V, Omar B Cureus. 2025; 17(1):e77255.

PMID: 39931606 PMC: 11807912. DOI: 10.7759/cureus.77255.

Treatment Options for Nosocomial Ventriculitis/Meningitis: A Case Report and Review of the Literature.

Karvouniaris M, Aidoni Z, Gkeka E, Primikyri S, Pagioulas K, Argiriadou E Pathogens. 2025; 14(1).

PMID: 39860964 PMC: 11768174. DOI: 10.3390/pathogens14010003.

Comprehensive Study of Antibiotic Resistance in spp.: Comparison of Influents and Effluents of Wastewater Treatment Plants.

Park J, Bae K, Kang J, Park E, Yoon J Antibiotics (Basel). 2024; 13(11).

PMID: 39596765 PMC: 11590936. DOI: 10.3390/antibiotics13111072.

Fosfomycin-Overcoming Problematic In Vitro Susceptibility Testing and Tricky Result Interpretation: Comparison of Three Fosfomycin Susceptibility Testing Methods.

Zavora J, Kroneislova G, Kroneisl M, Adamkova V Antibiotics (Basel). 2024; 13(11).

PMID: 39596744 PMC: 11590952. DOI: 10.3390/antibiotics13111049.

References

Olawale K, Fadiora S, Taiwo S . Prevalence of hospital-acquired enterococci infections in two primary-care hospitals in osogbo, southwestern Nigeria. Afr J Infect Dis. 2013; 5(2):40-6. PMC: 3497844. DOI: 10.4314/ajid.v5i2.66513. View

Lee D, Choe H, Lee S, Bae W, Cho H, Yoon B . Antimicrobial susceptibility pattern and epidemiology of female urinary tract infections in South Korea, 2010-2011. Antimicrob Agents Chemother. 2013; 57(11):5384-93. PMC: 3811252. DOI: 10.1128/AAC.00065-13. View

Wang C, Li W, Gao J, Zhang D, Li Y, Li F . Microbial Predominance and Antimicrobial Resistance in a Tertiary Hospital in Northwest China: A Six-Year Retrospective Study of Outpatients and Patients Visiting the Emergency Department. Can J Infect Dis Med Microbiol. 2020; 2020:8838447. PMC: 7719506. DOI: 10.1155/2020/8838447. View

Esfahani S, Ahmadrajabi R, Mollaei H, Saffari F . Co-Incidence of Type II Topoisomerase Mutations and Efflux Expression in High Fluoroquinolone Resistant Isolated from Urinary Tract Infections. Infect Drug Resist. 2020; 13:553-559. PMC: 7035903. DOI: 10.2147/IDR.S237299. View

Rostkowska O, Kuthan R, Burban A, Salinska J, Ciebiera M, Mlynarczyk G . Analysis of Susceptibility to Selected Antibiotics in and Causing Urinary Tract Infections in Kidney Transplant Recipients over 8 Years: Single-Center Study. Antibiotics (Basel). 2020; 9(6). PMC: 7344424. DOI: 10.3390/antibiotics9060284. View

Boost M, Lai L, ODonoghue M . Drug resistance in fecal enterococci in Hong Kong. J Infect Chemother. 2004; 10(6):326-30. DOI: 10.1007/s10156-004-0337-z. View

Lin Z, Pu Z, Xu G, Bai B, Chen Z, Sun X . Omadacycline Efficacy against Enterococcus faecalis Isolated in China: Activity, Heteroresistance, and Resistance Mechanisms. Antimicrob Agents Chemother. 2019; 64(3). PMC: 7038293. DOI: 10.1128/AAC.02097-19. View

Azzam A, Elkafas H, Khaled H, Ashraf A, Yousef M, Elkashef A . Prevalence of Vancomycin-resistant enterococci (VRE) in Egypt (2010-2022): a systematic review and meta-analysis. J Egypt Public Health Assoc. 2023; 98(1):8. PMC: 10086090. DOI: 10.1186/s42506-023-00133-9. View

Heidari H, Emaneini M, Dabiri H, Jabalameli F . Virulence factors, antimicrobial resistance pattern and molecular analysis of Enterococcal strains isolated from burn patients. Microb Pathog. 2015; 90:93-7. DOI: 10.1016/j.micpath.2015.11.017. View

10.

De Lorenzis E, Alba A, Cepeda M, Galan J, Geavlete P, Giannakopoulos S . Bacterial spectrum and antibiotic resistance of urinary tract infections in patients treated for upper urinary tract calculi: a multicenter analysis. Eur J Clin Microbiol Infect Dis. 2020; 39(10):1971-1981. DOI: 10.1007/s10096-020-03947-z. View

11.

Cirrincione S, Neumann B, Zuhlke D, Riedel K, Pessione E . Detailed Soluble Proteome Analyses of a Dairy-Isolated : A Possible Approach to Assess Food Safety and Potential Probiotic Value. Front Nutr. 2019; 6:71. PMC: 6533484. DOI: 10.3389/fnut.2019.00071. View

12.

Sader H, Watters A, Fritsche T, Jones R . Daptomycin antimicrobial activity tested against methicillin-resistant staphylococci and vancomycin-resistant enterococci isolated in European medical centers (2005). BMC Infect Dis. 2007; 7:29. PMC: 1865382. DOI: 10.1186/1471-2334-7-29. View

13.

Reinseth I, Ovchinnikov K, Tonnesen H, Carlsen H, Diep D . The Increasing Issue of Vancomycin-Resistant Enterococci and the Bacteriocin Solution. Probiotics Antimicrob Proteins. 2019; 12(3):1203-1217. PMC: 8613153. DOI: 10.1007/s12602-019-09618-6. View

14.

Toc D, Botan A, Botescu A, Brata V, Colosi I, Costache C . A Tale of Two Pandemics: Antimicrobial Resistance Patterns of spp. in COVID-19 Era. Antibiotics (Basel). 2023; 12(2). PMC: 9952321. DOI: 10.3390/antibiotics12020312. View

15.

Moher D, Liberati A, Tetzlaff J, Altman D . Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009; 6(7):e1000097. PMC: 2707599. DOI: 10.1371/journal.pmed.1000097. View

16.

Iseppi R, Cerbo A, Messi P, Sabia C . Antibiotic Resistance and Virulence Traits in Vancomycin-Resistant Enterococci (VRE) and Extended-Spectrum β-Lactamase/AmpC-producing (ESBL/AmpC) from Humans and Pets. Antibiotics (Basel). 2020; 9(4). PMC: 7235867. DOI: 10.3390/antibiotics9040152. View

17.

Djahmi N, Boutet-Dubois A, Nedjai S, Dekhil M, Sotto A, Lavigne J . Molecular epidemiology of Enterococcus sp. isolated in a university hospital in Algeria. Scand J Infect Dis. 2012; 44(9):656-62. DOI: 10.3109/00365548.2012.673232. View

18.

Adeniji O, Nontongana N, Okoh A . Prevalence of Class 1 Integron and In Vitro Effect of Antibiotic Combinations of Multidrug-Resistant Species Recovered from the Aquatic Environment in the Eastern Cape Province, South Africa. Int J Mol Sci. 2023; 24(3). PMC: 9917988. DOI: 10.3390/ijms24032993. View

19.

Sharma A, Singh A, Dar M, Kaur R, Charan J, Iskandar K . Menace of antimicrobial resistance in LMICs: Current surveillance practices and control measures to tackle hostility. J Infect Public Health. 2021; 15(2):172-181. DOI: 10.1016/j.jiph.2021.12.008. View

20.

Jiang G, Li J, Long H, Qiulin C, Jin R, Yaodong Y . Study on risk factors, bacterial species, and drug resistance of acute pyelonephritis associated with ureteral stent after percutaneous nephrolithotomy. Eur J Clin Microbiol Infect Dis. 2020; 40(4):707-713. PMC: 7979655. DOI: 10.1007/s10096-020-04050-z. View